Mirabegron: useful side effects and new promising areas of application

Introduction. Mirabegron is a fi3-adrenergic receptor agonist (fi3-AR) that is registered and widely used for the treatment of overactive bladder (OAB). Initially the drug was studied for the treatment of metabolic syndrome, but then showed the ability to influence the symptoms of urgent frequent urination. As a result, it was registered for the indication «OAB». However, the effect of mirabegron on fat metabolism and other metabolic effects should also be taken into account. These side effects of mirabegron can be «beneficial» and provide a dual effect: correction of symptoms of lower urinary tract dysfunction (LUTS) and, for example, metabolic disorders. This review is devoted to the analysis of publications that demonstrate concomitant beneficial effects of mirabegron.